Xiao-Fan Wang | Academic Influence

Xiao-Fan Wang's AcademicInfluence.com Rankings

Xiao-Fan Wang

Engineering

#7720

World Rank

#9132

Historical Rank

Electrical Engineering

#2418

World Rank

#2533

Historical Rank

engineering Degrees

Xiao-Fan Wang

Computer Science

#10447

World Rank

#10973

Historical Rank

Computational Linguistics

#2634

World Rank

#2660

Historical Rank

Machine Learning

#4777

World Rank

#4831

Historical Rank

Artificial Intelligence

#5145

World Rank

#5212

Historical Rank

computer-science Degrees

Download Badge

Engineering
Computer Science

Xiao-Fan Wang's Degrees

PhD Computer Science Stanford University
Masters Electrical Engineering Stanford University

Similar Degrees You Can Earn

Best Online PhD of Computer Science (Doctorates) 2025

Why Is Xiao-Fan Wang Influential?

(Suggest an Edit or Addition)

According to Wikipedia, Xiao-Fan Wang is a Chinese-American oncologist. He is the Donald and Elizabeth Cooke Professor of Cancer Research at Duke University School of Medicine. Biography Wang was born in Ürümqi, Xinjiang, China in 1955. His family moved to a village in Henan province in the 1970s, during the Cultural Revolution, his mother was imprisoned by local government for "historical questions". Wang was raised by his paternal grandmother. Before graduating from primary school, he was assigned to work as a worker in a factory for 8 years. After resuming the college entrance examination, he entered Wuhan University, majoring in biochemistry, where he graduated in 1982. After college, he was accepted to the Chinese Academy of Sciences, he attended the China-United States Biochemistry Examination and Application and was sent abroad to study at the expense of the Chinese government with his wife Xinnian Dong. Wang earned his doctor's degree in biology from the University of California, Los Angeles in 1986. He did post-doctoral research at the Whitehead Institute for Biomedical Research, Massachusetts Institute of Technology from 1987 to 1992 under Professor Robert Weinberg.

(See a Problem?)

Xiao-Fan Wang's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

HDAC6 is a microtubule-associated deacetylase (2002) (2056)
TGFβ signals through a heteromeric protein kinase receptor complex (1992) (1430)
Expression cloning of the TGF-β type II receptor, a functional transmembrane serine/threonine kinase (1992) (1042)
Signaling cross-talk between TGF-β/BMP and other pathways (2009) (839)
Expression cloning and characterization of the TGF-β type III receptor (1991) (617)
Notch Promotes Radioresistance of Glioma Stem Cells (2009) (612)
Periostin potently promotes metastatic growth of colon cancer by augmenting cell survival via the Akt/PKB pathway. (2004) (509)
Functional Analysis of the Transforming Growth Factor βResponsive Elements in the WAF1/Cip1/p21 Promoter (*) (1995) (475)
TGF-β-miR-34a-CCL22 signaling-induced Treg cell recruitment promotes venous metastases of HBV-positive hepatocellular carcinoma. (2012) (442)
Smad3 deficiency attenuates bleomycin-induced pulmonary fibrosis in mice. (2002) (396)
Transgenic anopheline mosquitoes impaired in transmission of a malaria parasite (2002) (354)
Essential Role of Smad3 in Infarct Healing and in the Pathogenesis of Cardiac Remodeling (2007) (339)
Smad3 Signaling Critically Regulates Fibroblast Phenotype and Function in Healing Myocardial Infarction (2010) (333)
Targeting Interleukin 6 Signaling Suppresses Glioma Stem Cell Survival and Tumor Growth (2009) (324)
miR-126 and miR-126* repress recruitment of mesenchymal stem cells and inflammatory monocytes to inhibit breast cancer metastasis (2013) (324)
Acquired Expression of Periostin by Human Breast Cancers Promotes Tumor Angiogenesis through Up-Regulation of Vascular Endothelial Growth Factor Receptor 2 Expression (2004) (310)
Expression of transforming growth factor β type II receptor leads to reduced malignancy in human breast cancer MCF-7 cells (1994) (296)
ATR/ATM-mediated phosphorylation of human Rad17 is required for genotoxic stress responses (2001) (289)
Smad3-Smad4 and AP-1 Complexes Synergize in Transcriptional Activation of the c-Jun Promoter by Transforming Growth Factor β (1999) (282)
Smad3-dependent nuclear translocation of beta-catenin is required for TGF-beta1-induced proliferation of bone marrow-derived adult human mesenchymal stem cells. (2006) (277)
TGF-β Family Signaling in the Control of Cell Proliferation and Survival. (2017) (277)
Transforming Growth Factor β Activates the Promoter of Cyclin-dependent Kinase Inhibitor p15INK4B through an Sp1 Consensus Site (*) (1995) (267)
Combination therapy of inhibitors of epidermal growth factor receptor/vascular endothelial growth factor receptor 2 (AEE788) and the mammalian target of rapamycin (RAD001) offers improved glioblastoma tumor growth inhibition. (2005) (255)
The cytoplasmic deacetylase HDAC6 is required for efficient oncogenic tumorigenesis. (2008) (252)
The role of Smad3 in mediating mouse hepatic stellate cell activation (2001) (250)
Axin and GSK3- control Smad3 protein stability and modulate TGF- signaling. (2008) (244)
Transforming Growth Factor β-Mediated Transcriptional Repression of c-myc Is Dependent on Direct Binding of Smad3 to a Novel Repressive Smad Binding Element (2004) (231)
ß-Arrestin 2 Mediates Endocytosis of Type III TGF-ß Receptor and Down-Regulation of Its Signaling (2003) (221)
Extracellular matrix protein betaig-h3/TGFBI promotes metastasis of colon cancer by enhancing cell extravasation. (2008) (216)
SB-431542, a small molecule transforming growth factor-beta-receptor antagonist, inhibits human glioma cell line proliferation and motility. (2004) (207)
Nomenclature: Vertebrate Mediators of TGFβ Family Signals (1996) (189)
Role for the PP2A/B56δ Phosphatase in Regulating 14-3-3 Release from Cdc25 to Control Mitosis (2006) (188)
Requirement of protein phosphatase 5 in DNA-damage-induced ATM activation. (2004) (180)
The MEK Pathway Is Required for Stimulation of p21WAF1/CIP1 by Transforming Growth Factor-β* (1999) (172)
Inhibition of the 3-Hydroxy-3-methylglutaryl-coenzyme A Reductase Pathway Induces p53-independent Transcriptional Regulation of p21 WAF1/CIP1 in Human Prostate Carcinoma Cells* (1998) (172)
TGFβ‐stimulated Smad1/5 phosphorylation requires the ALK5 L45 loop and mediates the pro‐migratory TGFβ switch (2009) (165)
Bone-related Genes Expressed in Advanced Malignancies Induce Invasion and Metastasis in a Genetically Defined Human Cancer Model* (2003) (162)
The Loss of Smad3 Results in a Lower Rate of Bone Formation and Osteopenia Through Dysregulation of Osteoblast Differentiation and Apoptosis (2001) (161)
Cooperation of Sp1 and p300 in the induction of the CDK inhibitor p21WAF1/CIP1 during NGF-mediated neuronal differentiation (1999) (145)
Abnormal mouse lung alveolarization caused by Smad3 deficiency is a developmental antecedent of centrilobular emphysema. (2005) (136)
Tumor Initiating Cells in Esophageal Squamous Cell Carcinomas Express High Levels of CD44 (2011) (127)
The Activity of Guanine Exchange Factor NET1 Is Essential for Transforming Growth Factor-β-mediated Stress Fiber Formation* (2001) (122)
Molecular Mechanisms of Transforming Growth Factor-β Signaling (1998) (119)
Beta-arrestin 2 mediates endocytosis of type III TGF-beta receptor and down-regulation of its signaling. (2003) (117)
Secreted Protein Acidic, Rich in Cysteine (SPARC), Mediates Cellular Survival of Gliomas through AKT Activation* (2004) (116)
Microenvironmental regulation of cancer metastasis by miRNAs. (2014) (116)
Sorafenib suppresses postsurgical recurrence and metastasis of hepatocellular carcinoma in an orthotopic mouse model (2011) (107)
ATR functions as a gene dosage‐dependent tumor suppressor on a mismatch repair‐deficient background (2004) (105)
Bat3 facilitates H3K79 dimethylation by DOT1L and promotes DNA damage‐induced 53BP1 foci at G1/G2 cell‐cycle phases (2012) (98)
Essential Role for Smad3 in Regulating MCP-1 Expression and Vascular Inflammation (2004) (97)
A niche role for cancer exosomes in metastasis (2015) (93)
Stable RNA interference-mediated suppression of cyclophilin A diminishes non-small-cell lung tumor growth in vivo. (2005) (91)
MiR-215 Is Induced Post-transcriptionally via HIF-Drosha Complex and Mediates Glioma-Initiating Cell Adaptation to Hypoxia by Targeting KDM1B. (2016) (90)
Transforming Growth Factor-β-mediated p15INK4BInduction and Growth Inhibition in Astrocytes Is SMAD3-dependent and a Pathway Prominently Altered in Human Glioma Cell Lines* (1999) (89)
miR-33a promotes glioma-initiating cell self-renewal via PKA and NOTCH pathways. (2014) (83)
Protein Phosphatase 5 Is Required for ATR-Mediated Checkpoint Activation (2005) (82)
Smad3 Signaling Promotes Fibrosis While Preserving Cardiac and Aortic Geometry in Obese Diabetic Mice (2015) (81)
Ras induces p21Cip1/Waf1 cyclin kinase inhibitor transcriptionally through Sp1-binding sites (1999) (74)
Signaling by the transforming growth factor-β receptor (1995) (73)
Transforming Growth Factor-β1 Inhibition of Vascular Smooth Muscle Cell Activation Is Mediated via Smad3* (2004) (72)
Rad17 recruits the MRE11‐RAD50‐NBS1 complex to regulate the cellular response to DNA double‐strand breaks (2014) (69)
The hepatitis B virus-associated tumor microenvironment in hepatocellular carcinoma. (2014) (67)
Human tau protein forms complex with PrP and some GSS- and fCJD-related PrP mutants possess stronger binding activities with tau in vitro (2008) (67)
Protein Phosphatase 2A-Dependent Dephosphorylation of Replication Protein A Is Required for the Repair of DNA Breaks Induced by Replication Stress (2009) (65)
HIV-1 Vpr activates cell cycle inhibitor p21/Waf1/Cip1: a potential mechanism of G2/M cell cycle arrest. (2003) (62)
Transcriptional activation of p21(waf1/cip1) by alkylphospholipids: role of the mitogen-activated protein kinase pathway in the transactivation of the human p21(waf1/cip1) promoter by Sp1. (2004) (61)
The endogenous immunoglobulin heavy chain enhancer can activate tandem VH promoters separated by a large distance (1985) (61)
Expression of Transforming Growth Factor β (TGFβ) Type III Receptor Restores Autocrine TGFβ1 Activity in Human Breast Cancer MCF-7 Cells* (1997) (59)
Aven-Dependent Activation of ATM Following DNA Damage (2008) (56)
Chemerin suppresses hepatocellular carcinoma metastasis through CMKLR1-PTEN-Akt axis (2018) (54)
MiR-148a functions to suppress metastasis and serves as a prognostic indicator in triple-negative breast cancer (2016) (54)
NDRG4 Is Required for Cell Cycle Progression and Survival in Glioblastoma Cells* (2009) (54)
The N-terminus of PrP is responsible for interacting with tubulin and fCJD related PrP mutants possess stronger inhibitive effect on microtubule assembly in vitro. (2008) (52)
Restricted expression of type-II TGFβ receptor in murine embryonic development suggests a central role in tissue modeling and CNS patterning (1995) (51)
Dopamine and α-synuclein dysfunction in Smad3 null mice (2011) (50)
Transforming growth factor‐β signaling in cancer (2001) (50)
Activin induces hepatocyte cell growth arrest through induction of the cyclin-dependent kinase inhibitor p15INK4B and Sp1. (2004) (50)
A PK2/Bv8/PROK2 Antagonist Suppresses Tumorigenic Processes by Inhibiting Angiogenesis in Glioma and Blocking Myeloid Cell Infiltration in Pancreatic Cancer (2013) (47)
Proteolysis of Rad17 by Cdh1/APC regulates checkpoint termination and recovery from genotoxic stress (2010) (47)
Transforming Growth Factor β Stimulates the Human Immunodeficiency Virus 1 Enhancer and Requires NF-κB Activity (1998) (46)
Loss of phosphatase and tensin homologue increases transforming growth factor beta-mediated invasion with enhanced SMAD3 transcriptional activity. (2005) (45)
TLR agonists regulate PDGF‐B production and cell proliferation through TGF‐β/type I IFN crosstalk (2005) (44)
CHML promotes liver cancer metastasis by facilitating Rab14 recycle (2019) (44)
Casein Kinase Iϵ Plays a Functional Role in the Transforming Growth Factor-β Signaling Pathway* (2004) (43)
Cilia loss sensitizes cells to transformation by activating the mevalonate pathway (2018) (42)
SV40 enhancer-binding factors are required at the establishment but not the maintenance step of enhancer-dependent transcriptional activation (1986) (41)
Up-regulation of Tumor Susceptibility Gene 101 Conveys Poor Prognosis through Suppression of p21 Expression in Ovarian Cancer (2007) (40)
An Essential Role for Mad Homology Domain 1 in the Association of Smad3 with Histone Deacetylase Activity* (2001) (40)
EGF promotes mammalian cell growth by suppressing cellular senescence (2014) (40)
Human Rad9 is required for the activation of S‐phase checkpoint and the maintenance of chromosomal stability (2005) (39)
CD36 initiates the secretory phenotype during the establishment of cellular senescence (2018) (38)
Liver cancer: EphrinA2 promotes tumorigenicity through Rac1/Akt/NF‐κB signaling pathway (2010) (38)
SMAD3 deficiency promotes vessel wall remodeling, collagen fiber reorganization and leukocyte infiltration in an inflammatory abdominal aortic aneurysm mouse model (2015) (38)
Smad 3-Smad 4 and AP-1 Complexes Synergize in Transcriptional Activation of the c-Jun Promoter by Transforming Growth Factor b (1999) (37)
Resistance to receptor tyrosine kinase inhibition in cancer: molecular mechanisms and therapeutic strategies (2015) (37)
Nerve growth factor-induced Akt/mTOR activation protects the ischemic heart via restoring autophagic flux and attenuating ubiquitinated protein accumulation (2016) (33)
Loss of Smad3-Mediated Negative Regulation of Runx2 Activity Leads to an Alteration in Cell Fate Determination (2005) (33)
Reduced ATR or Chk1 expression leads to chromosome instability and chemosensitization of mismatch repair-deficient colorectal cancer cells. (2009) (32)
From breast to the brain: unraveling the puzzle of metastasis organotropism. (2009) (32)
Where PI3K/Akt meets Smads: the crosstalk determines human embryonic stem cell fate. (2012) (31)
Inflammation-Dependent IL18 Signaling Restricts Hepatocellular Carcinoma Growth by Enhancing the Accumulation and Activity of Tumor-Infiltrating Lymphocytes. (2016) (30)
Smad 3 deficiency attenuates bleomycin-induced pulmonary fibrosis in mice (2002) (30)
Transcriptome evidence reveals enhanced autophagy-lysosomal function in centenarians (2018) (29)
Switching off IMMP2L signaling drives senescence via simultaneous metabolic alteration and blockage of cell death (2018) (29)
Distinct Receptor Tyrosine Kinase Subsets Mediate Anti-HER2 Drug Resistance in Breast Cancer* (2016) (29)
Cancer-cell-derived GABA promotes β-catenin-mediated tumour growth and immunosuppression (2022) (27)
Human T‐cell leukemia virus type 1 Tax activates cyclin‐dependent kinase inhibitor p21/Waf1/Cip1 expression through a p53‐independent mechanism: Inhibition of cdk2 (2003) (26)
The histone deacetylase inhibitor trichostatin a decreases lymphangiogenesis by inducing apoptosis and cell cycle arrest via p21-dependent pathways (2016) (26)
A P(E)RM(I)T for BMP signaling. (2013) (21)
A Novel, Non-Apoptotic Role for Scythe/BAT3: A Functional Switch between the Pro- and Anti-Proliferative Roles of p21 during the Cell Cycle (2012) (21)
Trefoil factor 1 acts to suppress senescence induced by oncogene activation during the cellular transformation process (2011) (20)
Synthetic lethality between HER2 and transaldolase in intrinsically resistant HER2-positive breast cancers (2018) (19)
In vitro assays for the extracellular matrix protein-regulated extravasation process. (2008) (19)
UHRF1 is required for basal stem cell proliferation in response to airway injury (2017) (19)
TGFβ/Smad3 signal pathway is not required for epidermal langerhans cell development (2012) (19)
TGF b-stimulated Smad 1 / 5 phosphorylation requires the ALK 5 L 45 loop and mediates the pro-migratory TGF b switch (2009) (19)
A special issue on TGF-β signaling (2009) (19)
Transcriptional Activation of p 21 waf 1 / cip 1 by Alkylphospholipids : Role of the Mitogen-Activated Protein Kinase Pathway in the Transactivation of the Human p 21 waf 1 / cip 1 Promoter by Sp 1 (2004) (18)
Tumor-induced erythroid precursor-differentiated myeloid cells mediate immunosuppression and curtail anti-PD-1/PD-L1 treatment efficacy. (2022) (18)
Casein kinase Iepsilon plays a functional role in the transforming growth factor-beta signaling pathway. (2004) (18)
Removal of the glycosylation of prion protein provokes apoptosis in SF126. (2007) (18)
Cellular senescence: from anti-cancer weapon to anti-aging target (2020) (17)
Smads "freeze" when they ski. (2002) (17)
TGF- b Family Signaling in the Control of Cell Proliferation and Survival (2016) (17)
A Phosphatase Controls the Fate of Receptor-Regulated Smads (2006) (16)
Iron overload in hereditary tyrosinemia type 1 induces liver injury through the Sp1/Tfr2/hepcidin axis. (2016) (15)
Bat 3 Facilitates H 3 K 79 Dimethylation by DOT 1 L and Promotes DNA Damage-induced 53 BP 1 Foci at G 1 / G 2 Cell Cycle Phases (2012) (15)
A Pentapeptide Monocyte Locomotion Inhibitory Factor Protects Brain Ischemia Injury by Targeting the eEF1A1/Endothelial Nitric Oxide Synthase Pathway (2012) (15)
Differential effects of Smad3 targeting in a murine model of chronic kidney disease (2013) (15)
PPDPF alleviates hepatic steatosis through inhibition of mTOR signaling (2021) (13)
A Mediator Lost in the War on Cancer (2012) (13)
Dimethylfumarate effectively inhibits lymphangiogenesis via p21 induction and G1 cell cycle arrest (2016) (12)
The Viral Oncoprotein E 1 A Blocks Transforming Growth Factor b-Mediated Induction of p 21 / WAF 1 / Cip 1 and p 15 / INK 4 B (1997) (11)
Resident memory T cells in tumor-distant tissues fortify against metastasis formation (2020) (10)
HIF-miR-215-KDM1B promotes glioma-initiating cell adaptation to hypoxia (2016) (9)
Post-transcriptional regulation of MTA family by microRNAs in the context of cancer (2014) (9)
TGF-β-Regulated MicroRNAs and Their Function in Cancer Biology. (2016) (9)
A Patient With Creutzfeldt-Jakob Disease With an Insertion of 7 Octa-Repeats in the PRNP Gene: Molecular Characteristics and Clinical Features (2008) (8)
Acrylamide-regulated neurofilament expression in rat pheochromocytoma cells (2000) (8)
Inflammatory models drastically alter tumor growth and the immune microenvironment in hepatocellular carcinoma (2015) (7)
Carcinogen 7,12-dimethylbenz[a]anthracene-induced mammary tumorigenesis is accelerated in Smad3 heterozygous mice compared to Smad3 wild type mice (2016) (6)
Treatment of scrapie pathogen 263K with tetracycline partially abolishes protease-resistant activity in vitro and reduces infectivity in vivo. (2007) (6)
Finale: The Last Minutes of Smads (2009) (5)
Rad 17 recruits the MRE 11-RAD 50-NBS 1 complex to regulate the cellular response to DNA double-strand breaks (2014) (5)
GABAergic signaling beyond synapses: an emerging target for cancer therapy. (2022) (5)
TCR repertoire characteristics predict clinical response to adoptive CTL therapy against nasopharyngeal carcinoma (2021) (4)
5-18-2015 SMAD 3 deficiency promotes vessel wall remodeling , collagen fiber reorganization and leukocyte infiltration in an inflammatory abdominal aortic aneurysm mouse model (2017) (4)
[Interaction analysis between various PrP fusion proteins and the tubulin in vitro]. (2007) (4)
Reduced ATR or Chk 1 Expression Leads to Chromosome Instability and Chemosensitization of Mismatch Repair – deficient Colorectal Cancer Cells (2009) (3)
3 TGF-β: A Multipotential Cytokine (2008) (3)
Transforming Growth Factor-b-mediated p 15 INK 4 B Induction and Growth Inhibition in Astrocytes Is SMAD 3-dependent and a Pathway Prominently Altered in Human Glioma Cell Lines (1999) (3)
[Preliminary analyses for influence of mutant PrPs with different number of octapeptide]. (2007) (3)
Generation of genetic engineering monoclonal antibodies against prion protein (2007) (2)
SELECTION OF RECEPTOR VARIANTS FROM HUMAN AND AVIAN INFLUENZA ISOLATES WITH THE H3 HEMAGGLUTININ (1984) (2)
Isolation of Glioma-Initiating Cells for Biological Study. (2016) (2)
New secrets behind bone metastasis (2012) (2)
Abstract 3311: IL6-Stat3 signaling promotes glioma stem cell (GSC) survival under hypoxia environment through inhibition of cell-death inducing gene Bnip3 (2011) (1)
Intrahepatic landscape of regulatory T‐cell subsets in chronically HCV‐infected patients with cirrhosis and HCC (2014) (1)
[Interaction between various PrP segments and GFAP in vitro]. (2007) (1)
The TGFβ receptors and signaling pathways (1996) (1)
[Establishment of an assay for PrP(Sc) detection based on streptomycin precipitation]. (2008) (1)
Transforming Growth Factor-b-mediated p15 Induction and Growth Inhibition in Astrocytes Is SMAD3-dependent and a Pathway Prominently Altered in Human Glioma Cell Lines* (1999) (1)
Transcriptional Activation of p21waf1/cip1 by Alkylphospholipids (2004) (0)
TGF-² signaling Axin and GSK3-² control Smad3 protein stability and modulate (2008) (0)
SMAD3 SIGNALING CRITICALLY REGULATES INFARCT HEALING (2007) (0)
Establishment of cell free conversion system with biotin-labelled recombinant PrPsen expressed in E. coli. (2006) (0)
Functional Role of the Casein Kinase I (CKI) Family in the Transforming Growth Factor-Beta (TGF-Beta) Signaling Pathway (2003) (0)
Abstract 3345: Smad3 -/- Fibroblasts Are Hyperproliferative Cells With Impaired Migratory Capacity, Reduced Contractile Activity and Diminished Synthetic Function: Implications for Cardiac Repair and Remodeling (2009) (0)
Abstract 372: The Smad3 Pathway Critically Regulates Myofibroblast Proliferation And Synthetic Activity In Healing Myocardial Infarcts (2008) (0)
Up-regulation ofTumor Susceptibility Gene101Conveys Poor Prognosis through Suppression of p21Expression in Ovarian Cancer (2007) (0)
TGF-β activates gene expression (1994) (0)
The Effects of IGFBP3 Induction by TFG-B in Breast Tumorigenesis (2000) (0)
Abstract 5083: Investigating the development and therapeutic potential of intra-tumoral CXCR6+ effector/effector memory T cells (TEFF/EM) in triple-negative breast cancer (2023) (0)
SPARC/Osteonectin expression induces glioma invasion and survival under serum-free conditions (2004) (0)
Functional Analysis of SMAD Activation in TGF-B-mediated Negative Growth Control in Breast Epithelial Cells (1999) (0)
Cooperation Between TGF-β and Wnt Pathway Components in Regulating Mesenchymal Stem Cell Function (2008) (0)
Profile of Dr. Xiao-Fan Wang (2020) (0)
The Roles of TGF-Beta and TGF-Beta Signaling Receptors in Breast Carcinogenesis. (1995) (0)
TGFβ Signaling Mechanisms (2002) (0)
Abstract C13: Targeting interleukin 6 signaling suppresses glioma stem cell survival and tumor growth (2009) (0)
Analysis of the Link Between Acquired Expression of a Master Switch Gene of Osteoblast Differentiation by Breast Cancer and Bone Metastasis (2004) (0)
Targeting YAP-mediated hepatic stellate cell death susceptibility and senescence for treatment of liver fibrosis. (2023) (0)
Abstract 2482: Bat3 facilitates histone H3 lysine 79 dimethylation by DOT1L to promote ionizing radiation-induced 53BP1 foci formation during G1- and G2-phases of the cell cycle (2011) (0)
Functional Analysis of TGFRP, a Putative Angiogenic Factor, in Breast Carcinogenesis (2001) (0)
Receptor type III TGF-beta, cDNA encoding it and its uses. (1992) (0)
Targeting senescent hepatocytes using the THBD-PAR1 inhibitor Vorapaxar ameliorates NAFLD progression. (2023) (0)
The in vivo role of Sma3 in mediating CCl4 induced liver fibrosis (2000) (0)
PPDPF Promotes the Development of Mutant KRAS‐Driven Pancreatic Ductal Adenocarcinoma by Regulating the GEF Activity of SOS1 (2022) (0)
COUP-TFII and AKT are cancer targets pursued by SCBA award winners (2014) (0)
Xiao-Fan Wang emphysema deficiency is a developmental antecedent of centrilobular Abnormal mouse lung alveolarization caused by Smad 3 (2005) (0)
Abstract 4109: EphrinA2 promotes tumorigenicity through Rac1/Akt/NF-kappa B signaling pathway in liver cancer (2010) (0)
Breast Tumorigenesis: Interaction of Two Signaling Pathways- -TGF- -beta versus Estrogen Receptor. (1997) (0)
ATR-Mediated Checkpoint Activation Protein Phosphatase 5 Is Required for (2005) (0)
Functional Characterization of TPF (Tumor Promoting Factor), A Novel Angiogenic Factor in Breast Cancer Pathogenesis (2004) (0)
Abstract 3536: Roles of miR-215 and regulatory mechanisms for its biogenesis in response to hypoxia in glioblastoma stem cells (2014) (0)
Cloning and Characterization of the Receptor for TPF (Tumor Promoting Factor), A Novel Angiogenic Factor (2002) (0)
Abstract 4070: Carcinogen 7,12-dimethylbenz[a]anthracene-induced mammary tumorigenesis is accelerated in Smad3 heterozygous mice compared to Smad3 wild type mice (2016) (0)

This paper list is powered by the following services:

Other Resources About Xiao-Fan Wang

en.wikipedia.org

What Schools Are Affiliated With Xiao-Fan Wang?

Xiao-Fan Wang is affiliated with the following schools: